COVID-19 Vaccine Trials Recruiting Participants
Volunteer Helen said she put her hand up because she wanted to help "get the world back to normal".
Are you interested in participating in one of our COVID-19 Vaccine studies? All studies are currently fully booked, but you can register your interest now for future dates.
Participating in a clinical trial
From a new vaccine through to treatments to manage cardiovascular conditions, diabetes, or Alzheimer’s; clinical trials play a vital role in transforming discoveries into treatments for patients and the broader community. By participating in one of our clinical trials, you play a real role in advancing medicine and improving lives.
You will be treated with the utmost care and supported every step of the way. You will also be reimbursed up to $360 per day for your time.
This is your chance to help make a real difference!
At Nucleus Network we run early-stage clinical trials for some of the world’s leading pharmaceutical and biotechnology companies.
We are always happy to speak to potential participants at 1800 243 733.
Our Unique Offering
Nucleus Network is the only Phase 1 clinical research organization in the world to have Phase 1 facilities located in Australia and the USA. We are Australia’s largest Phase 1 clinical research organization and one of the few specialized units in the USA capable of delivering Phase 1 hepatic and renal clinical trials.
Nucleus Network is uniquely positioned to help administer your clinical trial with our four key advantages:
Each of our Phase 1 facilities have focused areas of specialization and extensive internal and external capabilities to support the complex requirements of Phase 1 clinical trials.
Our Phase 1 facilities are supported by a highly trained and dedicated team of medical personnel (FRACP), including clinical pharmacologists, oncologists, nephrologists and infectious disease physicians.
Our Australian Phase 1 facilities are strategically co-located within prominent Hospitals and our USA Phase 1 facility benefits from co-locating within a Life Sciences and Biomedical Research Precinct.
The data generated from Nucleus Network is used to support IND and NDA regulatory filings for the USA FDA. Data is also used for EMA, PMDA and Health Canada regulatory filings.
In excess of
Phase 1 clinical trials conducted
years’ experience conducting Phase 1 clinical trials
Phase 1 clinical trial beds
Access to over
total population across Brisbane and Melbourne (Australia)
As well as
total population across Minneapolis – Saint Paul (USA)
sponsor audits, including FDA and EMA regulatory inspections